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Abstract 1 
Serotonin (5-HT) affects multiple physiological processes in the brain and is involved in a 2 
number of psychiatric disorders. 5-HT axons reach all cortical areas; however, the precise 3 
mechanism by which 5-HT modulates cortical network activity is not yet fully understood. We 4 
investigated the effects of 5-HT on slow oscillations (SO), a synchronized cortical network 5 
activity universally present across species. SO are observed during slow-wave sleep and 6 
anesthesia and are considered the default cortical activity pattern. Combining opto- and 7 
pharmacogenetic manipulations with electrophysiological recordings, we discovered that 5-8 
HT inhibits SO within the entorhinal cortex (EC) by activating somatostatin-expressing (Som) 9 
interneurons via the 5-HT2A receptor (5-HT2AR). This receptor is involved in the etiology of 10 
different psychiatric disorders and mediates the psychological effects of many psychoactive 11 
serotonergic drugs, suggesting that 5-HT targeting of Som interneurons may play an 12 
important role in these processes.  13 
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2 
Introduction 14 
5-HT is one of the most important neuromodulators in the central nervous system. Projections 15 
originating from the Raphe nuclei, the brain-stem structure that comprises the majority of 5-16 
HT releasing neurons in the brain, reach all cortical and sub-cortical area (Descarries et al., 17 
2010). Consequentially, it is not surprising that 5-HT is involved in the regulation of a myriad 18 
of physiological functions (e.g. circadian rhythm, mood, memory formation, reward encoding, 19 
sexual behavior) and psychiatric disorders including depression, autism, schizophrenia, and 20 
anxiety disorders (Monti, 2011, Underwood et al., 2018, Hayes and Greenshaw, 2011, Teixeira et al., 21 
2018, Uphouse and Guptarak, 2010, Nakai et al., 2017).  22 
5-HT levels in the brain are closely linked to the sleep-wake cycle. Activity of serotonergic 23 
raphe neurons is increased during wakefulness, decreased during slow-wave sleep and 24 
virtually silent during REM sleep (McGinty and Harper, 1976, Oikonomou et al., 2019). Cortical 25 
activity is also influenced by the behavioral state of the animal: slow-wave sleep (SWS) is 26 
generally associated to “synchronized” patterns of activity, characterized by low-frequency 27 
global fluctuations, whereas active wakefulness and REM sleep features “desynchronized” 28 
network activity in which low-frequency fluctuations are absent. The shifting of cortical 29 
networks between different patterns of activity is controlled, at least in part, by 30 
neuromodulators (Lee and Dan, 2012). For instance, Acetylcholine (Ach) can profoundly alter 31 
cortical network activity by inducing desynchronization via activation of Som interneurons 32 
(Chen et al., 2015). However, it is not solely responsible for cortical desynchronization as lesions 33 
of cholinergic neurons are not sufficient to abolish desynchronization (Kaur et al., 2008). On the 34 
other hand, blocking Ach and 5-HT transmission at the same time causes a complete 35 
suppression of cortical desynchronization, even during active behavior, thus suggesting that 36 
5-HT plays an important role in desynchronization  (Vanderwolf and Baker, 1986). In agreement 37 
with this line of thought, electrical and optogenetic stimulation of the Raphe nuclei reduce low 38 
frequency (1-10 Hz) power in the cortex thus promoting desynchronization (Puig et al., 2010, 39 
Grandjean et al., 2019). Moreover, optogenetic stimulation of serotonergic neurons at a 40 
physiological frequency (25 Hz) is sufficient to wake up mice from SWS (Oikonomou et al., 41 
2019). These data suggest a causal relationship between 5-HT levels and cortical activity (Lee 42 
and Dan, 2012, Harris and Thiele, 2011). The exact mechanism by which 5-HT modulates network 43 
activity in the cortex is, however, still not fully understood. 44 
Here, we used electrophysiological techniques together with pharmacology, optogenetics 45 
and pharmacogenetics to investigate the effect of 5-HT on SO, a network oscillation 46 
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characterized by synchronized transitions (< 1 Hz) between periods of high activity (up-state) 47 
and relative quiescence (down-state) (Steriade et al., 1993, Neske, 2015). SO are a global 48 
phenomenon observed throughout the cerebral cortex and are considered to be the default 49 
emergent activity of cortical networks during slow wave-sleep and anesthesia (Neske, 2015, 50 
Sanchez-Vives et al., 2017). Our results show that 5-HT release in vivo is sufficient to suppress 51 
SO and, concurrently, activate a small group of neurons characterized by an intermediate 52 
waveform shape. Using cortical brain slices, we were able to characterize the 5-HT activated 53 
neurons as Som-expressing interneurons and show that they are necessary mediators of the 54 
effect of 5-HT on SO in vitro. While previous studies have shown that parvalbumin (PV) 55 
interneurons are excited by 5-HT (Puig et al., 2010, Athilingam et al., 2017), our results identify 56 
cortical Som interneurons as novel targets of the 5-HT neuromodulatory system. 57 
Results 58 
5-HT inhibits SO in vivo  59 
We investigated the effect of 5-HT on network activity in anesthetized mice using multisite 60 
silicon microelectrodes placed in the entorhinal cortex (EC), a region located in the medial 61 
temporal lobe interconnected to a variety of cortical and subcortical areas (Figure 1A-B, Figure 62 
1–figure supplement 1) including the Raphe nuclei (Figure 1C) (van Strien et al., 2009, Muzerelle 63 
et al., 2016). Under urethane anesthesia, EC, like the rest of the cortex, displays SO (Figure 1–64 
figure supplement 2). As expected, we found that up-states were present synchronously in 65 
the local field potential (LFP) of all the recording channels (Figure 1–figure supplement 3) and 66 
every up-state coincided with large increases in population spiking activity (Figure 1D). 5-HT 67 
does not cross the blood brain barrier (Hardebo and Owman, 1980), therefore, to understand the 68 
effect of 5-HT on SO we used (±)3,4-methylenedioxymethamphetamine (MDMA), a potent 69 
presynaptic 5-HT releaser and popular recreational drug (Green et al., 2003). Intraperitoneal 70 
injections of MDMA (1.25 mg/kg) caused a strong suppression of up-state incidence (Figure 71 
1G-J), a decrease in power of delta frequencies (Figure 1H), and a reduction of population 72 
spiking activity (Figure 1I-K). MDMA also causes, although to a lesser extent, the release of 73 
dopamine and noradrenaline (Green et al., 2003). To test whether the effect of MDMA was 74 
mediated specifically by 5-HT we repeated the experiment using fenfluramine (Fen) (5 mg/kg), 75 
a more selective 5-HT releaser (Rothman and Baumann, 2002). Intraperitoneal injection of Fen 76 
had a comparably strong suppressive effect on both the occurrence of up-states and  77 
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population spiking activity (Figure 1J-K). This shows that 5-HT released from raphe neurons 78 
is capable of modulating ongoing oscillatory activity and suppress low-frequency fluctuations. 79 
Figure 1| MDMA inhibits SO in vivo. (A) Map of EC output connectivity registered to the Allen 80 
mouse common coordinate framework. Circle size represents projection energy (see 81 
“Supplementary Materials and Methods”). Circle color encodes area location according to the Allen 82 
institute standard: green = cerebral cortex, blue= cerebral nuclei, pink = midbrain, red = 83 
interbrain/hindbrain and yellow = cerebellum. (B) Scatter plot showing relationship between 84 
projection distance and projection energy. (C) Immunostaining of an ePet-YFP mouse showing 85 
serotonergic fibers in medial entorhinal cortex, horizontal slice (M = medial, L = lateral, P= posterior, 86 
A = anterior). Scale bar: 20 µm. (D) LFP (top) and instantaneous population activity (bottom) of a 87 
representative in vivo recording during SO (spikes/s units in thousands), cyan rectangles represent 88 
detected up-states. (E) 3D visualization of the microelectrode location of the recording shown in g. 89 
EC represented in grey. (F) Left: microelectrode tracks (red) of the recording shown in (G). Right: EC 90 
position represented in green. (G) Top: Cyan lines represent detected up-states. Bottom: LFP (black) 91 
and average up-state incidence per minute (cyan). Pink dotted line represents MDMA application 92 
time. (H) Fourier transformation and (I) instantaneous population activity for the recording shown in 93 
G (spikes/s units in thousands).  (J) Mean up-state incidence after saline (control), Fen or MDMA 94 
application (control: n = 5, Fen: n = 6, MDMA: n = 7; p < 10-4, unpaired t test with Holm-Sidak 95 
correction). (K) Mean normalized spike rate after saline (control), Fen or MDMA application (control: 96 
n = 5, Fen: n = 6, MDMA: n = 7; p < 10-4, unpaired t test with Holm-Sidak correction). 97 
5-HT activates a subgroup of cortical neurons  98 
Besides the LFP signal, we recorded the activity of 355 single units within the EC. Because of 99 
the very similar effects of MDMA and Fen on spike rates (Figure 1K), we pooled all units 100 
recorded in both types of experiments. We found that drug injections differentially affected  101 
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Figure 2| Divergent unit responses to MDMA/Fen application. (A) Spike rate of the 102 
activated units versus all the other units during MDMA/Fen application (activated: n = 31, 103 
Non-activated: n = 324). (B) Top: TP latencies color-coded by group. Middle: cumulative 104 
distribution of TP latencies (Kolmogorov-Smirnov test, pActivated vs Int < 10-4, pActivated vs Exc < 10-4). 105 
Bottom: bar plot representing probability distribution of TP latencies, on the right y axis 106 
dashed line representing the percentage of ‘activated’ units per TP latency bin. (C) 107 
Distribution of units according to trough-to-peak (TP) latencies and repolarization time, units 108 
were classified as putative interneurons (Int, blue) and putative excitatory (Exc, dark gray) 109 
according to a threshold at 0.55 ms; activated units (red) could belong to either group but 110 
were mostly intermediate as shown by the covariance (2 STD) of each group (Ellipses). Units 111 
recorded during control experiments are represented by empty circles. (D) Waveforms of 112 
recorded units (n= 355). Units were divided into “putative excitatory” (black) and “putative 113 
inhibitory” (blue) neurons according to TP latencies. Units activated either by MDMA or Fen 114 
application are represented in red. Inset shows the average waveform for each group. Scale 115 
bars: 0.5 ms.   116 
spiking rates (Figure 2A) of recorded units: while spiking decreased in the majority of units 117 
(‘non-activated’), a small group of units (‘activated’) responded in the opposite fashion 118 
(n=31/355, 8,7%).  119 
.CC-BY-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted May 26, 2020. . https://doi.org/10.1101/2020.05.26.113373doi: bioRxiv preprint 
  
 
6 
Trough-to-peak (TP) latency of the spike waveform has been consistently used as a metric to 120 
classify units and, in accordance with previous studies (Senzai et al., 2019, Roux et al., 2014), we 121 
found a clear bimodal distribution of TP latencies distinguishing putative excitatory (Exc) and 122 
fast-spiking inhibitory (Int) groups. Analysis of cross-correlograms to infer monosynaptic 123 
connections confirmed the inhibitory nature of a subset of putative FS units (Figure 2–figure 124 
supplement 1) (Barthó et al., 2004). The cumulative distribution of TP latencies of ‘activated’ 125 
units was significantly different to both Exc and Int groups (Figure 2B). Specifically, the 126 
average TP latency of ‘activated’ units was situated in between the Int and Exc groups (Figure 127 
2B-D, Figure 2–figure supplement 2), possibly suggesting a non-fast spiking interneuron 128 
identity (Trainito et al., 2019, Kvitsiani et al., 2013).  129 
5-HT suppresses SO and activates Som interneurons via 5-HT2AR 130 
To understand the mechanism underlying the suppression of SO by 5-HT we combined 131 
electrophysiology and pharmacology in vitro. First, we recorded simultaneously from up to 132 
four neurons in the superficial layers of the EC (Figure 3A). Brain slices were perfused with an 133 
extracellular solution containing Mg2+ and Ca2+ in concentrations similar to physiological 134 
conditions. With this method we could reliably detect SO reminiscent of the in vivo network 135 
activity (Tahvildari et al., 2012). Release of 5-HT in vitro, induced by Fen application, caused a 136 
suppression of SO similar to what we observed in vivo (Figure 3–figure supplement 1). 137 
Likewise, application of low concentrations of 5-HT (5 µM) caused a suppression of SO (Figure 138 
3B, C). This effect was highly consistent across different slices and was readily reversible 139 
(Figure 3D). Similarly to spontaneous up-states, electrically evoked up-states (Neske et al., 140 
2015) were also suppressed by 5-HT (Figure 3–figure supplement 2). Increasing the stimulation 141 
intensity did not rescue up-state generation, indicating that lack of excitation alone cannot 142 
explain the suppressive effect of 5-HT on SO.  143 
Suppression of activity can have either an intrinsic or synaptic origin (Turrigiano, 2011). A 144 
substantial subset of EC excitatory neurons is known to express 5-HT1A receptor (5-HT1AR) 145 
and hyperpolarize upon 5-HT application via activation of G protein-coupled inwardly-146 
rectifying potassium (GIRK) channels (Figure 3–figure supplement 3E) (Schmitz et al., 1998, 147 
Chalmers and Watson, 1991). SO suppression, however, was not influenced by blocking 5-HT1AR 148 
(Figure 3–figure supplement 3A, F). In contrast, blocking 5-HT2AR with the selective antagonist 149 
ketanserin (Preller et al., 2018) strongly reduced the suppression power of 5-HT on SO from 95 150 
± 4% to 57 ± 10.1% (Figure 3–figure supplement 3B, F). The remaining suppression can be 151 
possibly explained by the activation of 5-HT1AR on excitatory cells, this is reflected by the  152 
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Figure 3| 5-HT suppresses SO and activates Som interneurons. (A) Biocytin staining of 153 
four simultaneously recorded cells shown in (B) WFS1 expression (in red) delimits L2/3 154 
border. (B) Intracellular recordings showing synchronous up-state events in 4 simultaneously 155 
recorded cells before (left) and after (right) 5-HT application. Scale bars: 1: 7.5 mV, 2: 25 mV, 156 
3: 25 mV, 4: 10 mV; 10 s. (C) Up-state raster plot before and after 5-HT application, orange 157 
box represents 5-HT application (n = 17, p < 10-4, Wilcoxon signed rank test). (D) 158 
Representative recording showing the temporary inhibitory effect of 5-HT on SO in two 159 
simultaneously recorded cells. Scale bars: 5 min, 20 mV. (E) PCA projection plot of all the 160 
cells recorded (n = 48). Cells are color coded according to group identity: Exc (black), FS 161 
(light blue) or LTS (green). Typical voltage responses to current injection (-150 and +250 pA) 162 
are plotted for each group. (F) Representative recording of an excitatory (black) and a low-163 
threshold (green) neuron simultaneously recorded during 5-HT application. Scale bars: 10 164 
mV, 30 s. (G) Average change of RP before and after 5-HT application, across excitatory, 165 
fast-spiking and low-threshold neurons (Exc: n = 34, FS: n = 6; LTS: n = 9; p < 10-4, unpaired 166 
t test with Holm-Sidak correction). (H) Left: Reconstruction of a recorded Som interneuron. 167 
Scale bar: 100 µm. Right: tdTomato expression in EC in a slice from a Som-tdTomato mouse. 168 
Inset shows a representative Som interneuron response to current injection (-150 and +250 169 
pA). Scale bar: 100 µm. (I) Representative recording of a Som interneuron during 5-HT 170 
application. Scale bars: 10 mV, 30 s. (L) Average RP of Som interneurons during 5-HT (red) 171 
and ketanserin +5-HT (blue) application, orange bar represents 5-HT. 172 
reduced spiking activity of putative excitatory cells (Figure 3–figure supplement 3D). Selective 173 
activation of 5-HT2R by α-methyl-5-HT could also replicate SO suppression (Figure 3–figure 174 
supplement 3C, F). Together, these results point to the importance of 5-HT2AR in the 175 
suppression of SO. 176 
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8 
5-HT2AR activation causes an increase in intracellular calcium and consequent depolarization 177 
of the resting potential (RP) (Nichols and Nichols, 2008). Accordingly, after 5-HT application, we 178 
found that a small group of neurons was depolarized (n= 6/48, 12,5%) (Figure 3–figure 179 
supplement 4). Using a soft clustering approach with six electrophysiological parameters (see 180 
“Materials and Methods”) we divided the recorded cells in 3 groups: Excitatory (Exc), fast-181 
spiking (FS) and low-threshold spiking (LTS) (Figure 3E, Figure 3–figure supplement 5). 182 
Strikingly, the cells excited by 5-HT belonged exclusively to the LTS group (Figure 3G, Figure 183 
3–figure supplement 4).  184 
A substantial part of LTS neurons expresses Som (Tremblay et al., 2016, Gibson et al., 1999), 185 
therefore we performed targeted patch-clamp recordings using a mouse line expressing 186 
tdTomato specifically in Som-expressing interneurons (Figure 3H). Som interneurons 187 
depolarized upon 5-HT application (n=19, ∆RP: 7.5 ± 1.23 mV) (Figure3I-L) and in some cases 188 
spiked while SO were suppressed (n= 8/17, 47.05%, mean spiking rate = 3.03 ± 0.39 spikes/s). 189 
This effect was blocked by ketanserin (n = 22) (Figure 3L). We confirmed the presence of 5-190 
HT2AR in Som interneurons using immunohistochemistry in mice expressing EGFP under the 191 
5-HT2AR promoter. We found that 11.8 ± 2.9 % of the 5-HT2AR positive cells in EC colocalized 192 
with Som (n = 7 mice) (Figure 3–figure supplement 6). These results suggest that Som 193 
interneurons might convey synaptic inhibition involved in the suppression of SO.  194 
Som interneurons mediate the suppression of SO by 5-HT  195 
To evaluate the contribution of Som interneurons to the 5-HT-mediated silencing of SO we 196 
used an opto- and pharmacogenetic approach. First, we transgenically expressed 197 
channelrhodopsin-2 (ChR2) in Som interneurons (Figure 4A). Light-stimulation of ChR2-198 
expressing Som interneurons in vitro suppressed SO consistently (Figure 4D-F). Expectedly, 199 
up-states associated spiking was also diminished (Figure 4C, E, F). At the end of the light 200 
stimulation spontaneous up-states immediately reoccurred (Figure 4G-H), in line with a critical 201 
role of Som interneurons in the modulation of SO (Fanselow et al., 2008, Funk et al., 2017, Niethard 202 
et al., 2018). While this experiment establishes the ability of Som interneurons to suppress SO, 203 
it does not causally link Som interneuron activation to the suppression of SO induced by 5-204 
HT. Therefore, we generated a transgenic mouse line carrying a Cre-conditional expression 205 
cassette of the pharmacogenetic silencer hM4Di (Figure 4–figure supplement 1) (Armbruster et 206 
al., 2007). Homozygous Cre-conditional hM4Di transgenic mice and Som-Cre mice were bred 207 
to obtain heterozygous Som-Cre/hM4Di offspring, which allow specific inhibition of Som 208 
interneuron activity using Clozapine-N-Oxide (CNO). Following application of 5-HT we  209 
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Figure 4| Som interneurons activation suppresses SO. (A) Experimental protocol: Som 210 
interneurons expressing ChR2 are activated by light during intracellular recording of layer 3 211 
neurons in EC. (B) Representative recordings from a L3 neuron during Som interneuron 212 
activation. Scale bars: 10 mV, 0.5 s. (C) Spikes raster (top) and density plot (bottom) during 213 
light stimulation. (D) Up-state raster (top) and density plot (bottom) during light stimulation. 214 
(E) Left: spike frequency during baseline light stimulation (n=14; p < 0.001, Wilcoxon signed 215 
rank test). Right: Up-state incidence during baseline and light stimulation (n=14; p < 0.001, 216 
Wilcoxon signed rank test). Patches represent 95% confidence interval, lines represent 217 
standard deviation. (F) Left: spike probability polar plot during Som interneurons light 218 
activation. Right: up-state probability polar plot during Som interneurons light activation. Note 219 
the absence of both spiking activity and up-states during Som interneurons activation. 220 
observed a strong reduction of up-state incidence in the LFP, which was partially restored by 221 
subsequent application of CNO (Figure 5 A-B). Activation of 5-HT1AR on excitatory cells and 222 
the resulting decreased network excitation drive might account for the remaining suppression 223 
effect of 5-HT. CNO did not show any significant effect in both wildtype littermates and 224 
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10 
hM4Di-PV mice (Figure 5–figure supplement 1), indicative of the specific role played by Som 225 
interneurons. In summary, while activation of Som interneurons either via 5-HT or directly by 226 
ChR2 suppresses SO, the pharmacogenetic inactivation of Som interneurons weakens the 227 
effect of 5-HT on SO.  228 
Figure 5| Som interneurons mediate the effect of 5-HT on SO. (A) Up-state raster plot 229 
during subsequent 5-HT and CNO application. Orange box represents 5-HT, purple boxes 230 
represent CNO. Note the appearance of up-states after CNO application. (B) Up-state 231 
incidence during 5-HT and 5-HT+CNO application (n=15; pbaseline vs 5-HT < 10-4, pbaseline vs CNO = 232 
0.0482, p5-HT vs CNO = 0.0405, Kruskal-Wallis test). Patches represent 95% confidence intervals, 233 
lines represent standard deviation. 234 
Discussion 235 
In this study we show that 5-HT suppresses default cortical network oscillations and, using 236 
an opto- and pharmacogenetic approach, we demonstrate that Som interneurons, activated 237 
by 5-HT2AR, mediate this suppression in mEC.  238 
Organization of cortical activity is brain state-dependent, ranging continuously from 239 
“synchronized” to “desynchronized” states (Harris and Thiele, 2011). SO is on one end of this 240 
continuum, representing the prototypical synchronized state. Our results, in line with previous 241 
studies (Puig et al., 2010, Grandjean et al., 2019, Oikonomou et al., 2019), show that 5-HT can 242 
suppress synchronized cortical activity; in addition, we identify Som interneurons as 243 
necessary for this desynchronization. A parsimonious explanation that links the activation of 244 
interneurons and desynchronization relies on tracking of shared input between inhibitory and 245 
excitatory populations (Sippy and Yuste, 2013, Renart et al., 2010, Stringer et al., 2016): increased 246 
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11 
inhibition, as shown both in computational model and experimental data, can override the 247 
effect of shared input causing net decorrelation. Som interneurons, in particular, are known 248 
to be sufficient to cause desynchronization in V1 (Chen et al., 2015). While it is well known that 249 
Som interneurons are potently excited by acetylcholine (Chen et al., 2015, Obermayer et al., 2018, 250 
Fanselow et al., 2008), our work identifies them as a novel target of 5-HT regulation via 5-HT2AR. 251 
The excitation of Som Interneurons by 5-HT is likely to contribute to the net inhibitory effect 252 
of 5-HT release in many cortical areas (Grandjean et al., 2019, Seillier et al., 2017, Azimi et al., 253 
2020), and could explain why the inhibition strength is linearly correlated to 5-HT2AR expression 254 
(Grandjean et al., 2019). Giving further support to this idea, Som interneurons in motor and 255 
somatosensory areas show increased cFos levels following 5-HT2AR activation (Martin and 256 
Nichols, 2016). Previous works have reported direct 5-HT2AR dependent inhibition in prefrontal 257 
cortex (PFC) (Abi-Saab et al., 1999, Ashby et al., 1990, Athilingam et al., 2017), piriform cortex 258 
(Marek and Aghajanian, 1994, Sheldon and Aghajanian, 1990), cingulate cortex (Zhou and Hablitz, 259 
1999), cochlear nucleus (Tang and Trussell, 2017), olfactory bulb (Petzold et al., 2009, Hardy et al., 260 
2005), visual cortex (Michaiel et al., 2019, Azimi et al., 2020) and hippocampus (Wyskiel and 261 
Andrade, 2016). However, none of these studies identified interneurons using molecular 262 
markers and we do not exclude that different interneuron classes in other cortical areas might 263 
mediate the inhibitory downstream effects of 5-HT2AR. For example, in PFC a subgroup of PV 264 
interneurons has been reported to be activated by this receptor (Athilingam et al., 2017, Puig et 265 
al., 2010).  266 
5-HT modulation is also involved in gain regulation. In olfactory cortex, 5-HT has a selective 267 
subtractive effect on stimulus evoked firing (Lottem et al., 2016), and a recent work has shown 268 
in visual cortex that the reduced gain of evoked responses is dependent on 5-HT2AR activation 269 
(Azimi et al., 2020). Intriguingly, Som interneurons have been shown to regulate subtractive 270 
inhibition (Sturgill and Isaacson, 2015, Wilson et al., 2012).  271 
Beside its involvement in various physiological brain processes, 5-HT is also associated with 272 
the etiology of various psychiatric disorders and the same applies for Som interneurons 273 
(Pantazopoulos et al., 2017, Lin and Sibille, 2015). 5-HT is also linked to the psychological effect 274 
of many psychotropic drugs. Most interestingly, 5-HT2AR activation is essential for the 275 
psychological effects induced by various psychedelics (Nichols, 2016) and, in the case of 276 
MDMA, has been linked to perceptual and emotional alterations (Liechti et al., 2000, Kuypers et 277 
al., 2018). Broadband reduction in oscillatory power, triggered by 5-HT2AR , seems to be linked 278 
to the subjective effect of serotonergic drugs (Carhart-Harris et al., 2016, Carhart-Harris and 279 
Friston, 2019) and it has been consistently observed in humans and rodents following 280 
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administration of MDMA (Frei et al., 2001, Lansbergen et al., 2011) or various other 5-HT2AR 281 
agonists (Kometer et al., 2015, Muthukumaraswamy et al., 2013, Carhart-Harris et al., 2016, Wood et 282 
al., 2012). The link between 5-HT2AR and perception is further supported by the fact that a 283 
number of routinely used antipsychotic drugs are potent 5-HT2AR antagonists (Marek et al., 284 
2003, Meltzer, 1999). While the most recent attempts to explain the psychological effects of 5-285 
HT2AR activation focus on the increased spiking of cortical pyramidal neurons in the deep 286 
layers (Carhart-Harris and Friston, 2019, Nichols, 2016), our study suggests that Som interneurons 287 
may also play a role. Som interneurons, in contrast to PV interneurons, biasedly form 288 
synapses on the dendrites of their target cell (Tremblay et al., 2016). A wealth of evidence 289 
suggests that active dendritic processing in cortical pyramidal neurons has a critical influence 290 
on sensory perception (Takahashi et al., 2016, Murayama et al., 2009, Smith et al., 2013, 291 
Ranganathan et al., 2018) and, in accordance to their unique anatomical properties, Som 292 
interneurons strongly influence dendritic computations and directly modulate perceptual 293 
thresholds (Takahashi et al., 2016). We propose that the novel link between 5-HT2AR and Som 294 
interneurons might help elucidate the mechanism underlying a host of psychiatric disorders 295 
and contribute to our understanding of how serotonergic drugs exert their psychological 296 
effects. 297 
  298 
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Materials and Methods 299 
All experiments were conducted according to regulations of the Landesamt für Gesundheit 300 
und Soziales (Berlin [T 0100/03], Berlin [G0298/18]) and the European legislation (European 301 
Directive 2010/63/EU).  302 
Animals 303 
Data for the in vivo part of the study were collected from C57BL6 mice (aged 6 to 10 weeks). 304 
Data for the in vitro part were collected from C57BL6 (P10-P17), Som-tdtomato (P10-P30), 305 
Sst-Chr2-EYFP (P10-P16), hM4Di-Som (P10-P15), hM4Di-Som (+/-) (P10-P15) and hM4Di-306 
PV (P10-P15) mice. Immunostainings to localize 5-HT2AR were performed on 5-HT2AR-EGFP 307 
mice (P20-P90) and Immunostainings to localize 5-HT fibers (Fig.1 c) were performed on an 308 
ePet-YFP mouse (P35). The animals were housed in a 12:12 hours light-dark cycle in singularly 309 
ventilated cages with ad libitum access to food and water. SO in vitro recordings were 310 
performed on P12-P16 mice. 311 
Drugs 312 
Urethane (U2500, Sigma), fenfluramine ((+)-Fenfluramine hydrochloride, F112, Sigma), 5-HT 313 
(Serotonin creatinine sulfate monohydrate, H7752, Sigma), WAY-100635 (W108, Sigma), α-314 
Methylserotonin (α-Methylserotonin maleate salt, M110, Sigma) MDMA ((±)3,4-315 
methylenedioxymethamphetamine, 64057-70-1, Sigma), CNO (Clozapine N-oxide 316 
dihydrochloride, 6329, Tocris) were dissolved in water for in vitro application and in 0.9% 317 
normal saline for in vivo application. Ketanserin (Ketanserin (+)-tartrate salt, S006, Sigma) was 318 
dissolved in Dimethyl sulfoxide (DMSO). 319 
Surgery and in vivo recording 320 
Mice were briefly anaesthetized with isofluorane (2%) and then injected intraperitoneally with 321 
urethane (1,2 g/kg, Sigma Aldrich, Munich, Germany). The level of anesthesia was maintained 322 
so that hindlimb pinching produced no reflex movement and supplemental doses of urethane 323 
(0.2 g/kg) were delivered as needed. Upon cessation of reflexes the animals were mounted 324 
on a stereotaxic frame (Kopf Instruments, Tujunga, California), and body temperature was 325 
maintained at 38°C. The scalp was removed, and the skull was cleaned with saline solution. 326 
A craniotomy was performed at +3 mm ML, -3 mm AP, +3.25 mm DV. 327 
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Extracellular recordings from EC were performed using a Cambridge Neurotech 64-channels 328 
(n = 15) or 32-channels (n = 3) silicon probe. The recording electrode was painted with the 329 
fluorescent dye DiI (Thermo Fisher Scientific, Schwerte, Germany) and then slowly lowered 330 
into the craniotomy using micromanipulators (Luigs&Neumann, Ratingen, Germany) at a 25° 331 
angle AP (toward the posterior side of the brain). The exposed brain was kept moist using 332 
saline solution. A ground wire connected to the amplifier was placed in the saline solution 333 
covering the skull to eliminate noise. Brain signals were recorded using a RHD2000 data 334 
acquisition system (Intan Technologies, Los Angeles, California) and sampled at 20 kHz. 335 
Recording quality was inspected on-line using the open-source RHD2000 Interface Software. 336 
Recordings began after a 10-minute waiting period in which clear Up-states could 337 
consistently be seen at a regular frequency.  338 
In vivo analysis 339 
We selected the channel to use for up-state detection based on the standard deviation (STD) 340 
of the trace during baseline (first 5 minutes of recording), the channel with the highest STD 341 
was selected as larger voltage deflection increases detection algorithm accuracy. Given the 342 
highly synchronous nature of SO (Supplementary Fig. 3) the spatial location of the channel 343 
selected was not considered. Up-states were detected comparing threshold crossing points 344 
in two signals: the delta-band filtered signal (0.5-4 Hz) and the population spike activity. 345 
Candidate up-states were identified in the delta-band filtered signal using two dynamic 346 
thresholds ‘a’ and ‘b’:  347 𝑎 = 𝑚 + 𝜎1.5 348 𝑏 = 𝑚 + 𝜎0.8 349 
Where σ is the standard deviation of the signal during the first five minutes of recording 350 
(baseline) and m is the centered moving median calculated using 60 s windows (Matlab 351 
function movmedian). The median was used instead of the mean to account for non-352 
stationaries in the data. A candidate up-state was identified at first using the threshold 353 
crossings of the signal compared to ‘a’: candidates shorter than 200 ms were deleted and 354 
candidates happening in a window of 300 ms were joined together. Subsequently the 355 
threshold ‘b’ was used to separate up-states occurring in close proximity: if the signal within 356 
one candidate crossed the threshold ‘b’ in more than one point then the candidate up-state 357 
was split in two at the midpoint between the two threshold crossings. Candidate up-states 358 
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were finally confirmed if the population spike activity (calculated in 100 ms windows) within 359 
the candidate crossed a threshold of 1 σ (calculated during the baseline). 360 
Units detection and classification 361 
Spike detection was performed offline using the template-based algorithm Kilosort2 362 
(https://github.com/MouseLand/Kilosort2), with the following parameters: 363 
§ ops.fshigh = 300 364 
§ ops.fsslow = 8000 365 
§ ops.minfr_goodchannels = 0 366 
§ ops.Th = [8 4] 367 
§ ops.Iam = 10 368 
§ ops.AUCsplit = 0.9 369 
§ ops.minFR = 1/1000 370 
§ ops.momentum = [20 400] 371 
§ ops.sigmaMask = 30 372 
§ ops.ThPre = 8 373 
§ ops.spkTh = -6 374 
§ ops.nfilt_factor = 8 375 
§ ops.loc_range = [3 1] 376 
§ ops.criterionNoiseChannel = 0.2 377 
§ ops.whiteningrange = 32 378 
§ ops.ntbuff = 64 379 
Manual curation of the results was performed using Phy (https://github.com/cortex-lab/phy). 380 
Each Isolated unit satisfied the following two criteria: Refractory period (2 ms) violations < 5%, 381 
fraction of spikes below detection threshold (as estimated by a gaussian fit to the distribution 382 
of the spike amplitudes) < 15%. Units with negative maximal waveform amplitude were further 383 
classified as putative excitatory if the latency (TP latency) was   0.55 ms or putative inhibitory 384 
when TP latency < 0.55 ms. The value 0.55 was chosen in accordance with previous works 385 
(Senzai et al., 2019, Antoine et al., 2019). Pharmacological classification: units were classified as 386 
‘activated’ if their firing rate in the 25 minutes following drug injection was 2 σ (standard 387 
deviation) above the baseline rate for at least 5 minutes. Remaining units were pulled together 388 
in the category ‘non-activated’. 389 
.CC-BY-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted May 26, 2020. . https://doi.org/10.1101/2020.05.26.113373doi: bioRxiv preprint 
  
 
16 
Cross-correlogram analysis 390 
Cross-correlogram based connectivity analysis was performed for every unit to identify 391 
inhibitory connections. Units with a spiking rate smaller than 0.3 spikes/s were discarded from 392 
the analysis. We used total spiking probability edges (TPSE) algorithm 393 
(https://github.com/biomemsLAB/TSPE) (De Blasi et al., 2019) to identify in a computationally 394 
efficient manner putative inhibitory connections between units and all clusters recorded. The 395 
parameters used were:  396 
 397 
§ d = 0,  398 
§ neg_wins = [2, 3, 4, 5, 6, 7, 8],  399 
§ co_wins = 0,  400 
§ pos_wins = [2, 3, 4, 5, 6],  401 
§ FLAG_NORM = 1.  402 
 403 
The connectivity vectors of each unit resulting from TSPE were sorted by inhibition strength. 404 
Top 20 connections were further analyzed using custom Matlab code. A connection was 405 
classified as inhibitory if the cross correlogram values (x) were smaller than the mean of x by 406 
more than one standard deviation (x < mean(x) – std(x)) in at least 4 consecutive bins (bin size 407 
= 1 ms) in a window 4 to 9 ms after the center of the cross-correlogram. 408 
Slice preparation 409 
We prepared acute near horizontal slices (∼15° off the horizontal plane) of the medial 410 
entorhinal cortex (mEC) from C57Bl6/n mice. Animals were decapitated following isoflurane 411 
anesthesia. The brains were quickly removed and placed in ice-cold (∼4° C) ACSF (pH 7.4) 412 
containing (in mM) 85 NaCl, 25 NaHCO3, 75 Sucrose, 10 Glucose, 2.5 KCl, 1.25 NaH2PO4, 413 
3.5MgSO4, 0.5 CaCl2, and aerated with 95% O2, 5% CO2. Tissue blocks containing the brain 414 
region of interest were mounted on a vibratome (Leica VT 1200, Leica Microsystems), cut at 415 
400 μm thickness, and incubated at 35 °C for 30 min. The slices were then transferred to 416 
ACSF containing (in mM) 85 NaCl, 25 NaHCO3, 75 Sucrose, 10 Glucose, 2.5 KCl, 1.25 417 
NaH2PO4, 3.5 MgSO4, 0.5 CaCl2. The slices were stored at room temperature in a 418 
submerged chamber for 1-5 hr before being transferred to the recording chamber. 419 
In vitro recording 420 
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In order to perform whole-cell recordings slices were transferred to a submersion style 421 
recording chamber located on the stage of an upright, fixed-stage microscope (BX51WI, 422 
Olympus) equipped with a water immersion objective (×60, Olympus) and a near-infrared 423 
charge-coupled device (CCD) camera. The slices were perfused with ACSF (∼35 °C bubbled 424 
with 95 % O2-5 % CO2) at 3-5 ml/ min to maintain neuronal health throughout the slice. The 425 
ACSF had the same composition as the incubation solution except for the concentrations of 426 
calcium and magnesium, which were reduced to 1.2 and 1.0 mM, respectively. Recording 427 
electrodes with impedance of 3-5 MΩ were pulled from borosilicate glass capillaries (Harvard 428 
Apparatus, Kent, UK; 1.5 mm OD) using a micropipette electrode puller (DMZ Universal Puller). 429 
The intracellular solution contained the following (in mM): 135 K-gluconate, 6 KCl, 2 MgCl2, 430 
0.2 EGTA, 5 Na2- phosphocreatine, 2 Na2-ATP, 0.5 Na2-GTP, 10 HEPES buffer, and 0.2% 431 
biocytin. The pH was adjusted to 7.2 with KOH. Recordings were performed using Multiclamp 432 
700A/B amplifiers (Molecular Devices, San Jose, California). The seal resistance was >1 GΩ. 433 
Capacitance compensation was maximal and bridge balance adjusted.  Access resistance 434 
was constantly monitored. Signals were filtered at 6 kHz, sampled at 20 kHz, and digitized 435 
using the Digidata 1550 and pClamp 10 (Molecular Devices, San Jose, California). Activation 436 
light was delivered by a 460 nm laser (DPSS lasers, Santa Clara, California) using a 460–480 437 
nm bandpass excitation filter. Stimulation consisted of 500 ms pulses at 1 Hz. 438 
Stimulation experiments were performed using a bipolar micro-electrode (glass pipette filled 439 
with ACSF solution, wrapped by a fine grounding wire) connected to an isolated voltage 440 
stimulator (ISO-Flex, A.M.P.I., Israel). A 4x objective (Olympus) was used to visually guide the 441 
stimulating electrode into the mEC. Stimulation power was adjusted to achieve consistent up-442 
state generation during baseline (> 95%). Each stimulus had a duration of 50 μs, inter-stimuli 443 
interval was 8-10 seconds. 444 
In vitro analysis  445 
In vitro up-states were detected in Matlab using an algorithm similar to the one described in 446 
the in vivo analysis method section. We used a coincident detection in two signals. In 447 
multicellular recordings we used the membrane potential of 2 cells, in single cell recording we 448 
used membrane potential and the envelope of the gamma filtered trace (50-250 Hz), as up-449 
states are characterized by an increase in gamma activity (Neske, 2015). 450 
Baseline condition was calculated using the last 120 s before drug application, post-drug 451 
application condition was calculated using the last 120 s of recording after drug application 452 
(Total recording duration: 600 s).  453 
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Excitatory (Exc), fast spiking (FS) and low-threshold spiking (LTS) neurons were classified 454 
using Gaussian mixture models (GMM) with a soft clustering approach in Matlab. Input 455 
resistance (Rin), Δafter-hyperpolarization (ΔAHP), sag, rheobase, spike width and resting 456 
potential (RP) were extracted from each neuron and used in the classification. The first two 457 
components of the principal component analysis (PCA) were used to fit the data to a Gaussian 458 
mixture model distribution. Initial values were set according to the k-means algorithm with 459 
centroid positioned at x and y position: 5, 0; -15, -15; -15, 10. This centroid were placed 460 
according to the loadings of the PCA to identify 3 clusters with the following main features:  461 
§ Cluster 1 (putative Exc): high spike width, low AHP, low rheobase. 462 
§ Cluster 2 (putative FS): low spike width, low SAG, high rheobase, low Rin. 463 
§ Cluster 3 (putative LTS): low spike width, high SAG, high AHP, high Rin. 464 
Covariance matrices were diagonal and not shared. Neurons with a posterior probability of 465 
belongings to any of the three clusters < 90% were discarded from further analysis (1/49). 466 
While the majority of Som-interneurons display LTS features, a minority (~10%) belongs to 467 
the FS group (Urban-Ciecko et al., 2015). To distinguish FS and LTS interneurons in the SOM-468 
Td Tomato mice we employed the GMM with posterior probability threshold of 90%. 469 
Inter-area connectivity analysis 470 
Projection data was downloaded from the from the Allen Mouse Brain Connectivity Atlas  via 471 
the provided API (application programming interface) using freely available code 472 
(https://github.com/SainsburyWellcomeCentre/AllenBrainAPI). Different connectivity metrics 473 
are provided for each experiment: 474 
 475 
• Normalized projection volume = -./01234/5	7/89:1;/3<8	7/89:1	/=	>4?5<8	45	4501234/5	>431 476 
• Projection density = @9:A1.	/=	B4C18>	4D1534=41D	<>	B./012345?	45	3E1	>3.9239.1	@9:A1.	/=	7<84D	B4C18>	45	3E1	>3.9239.1   477 
• Projection intensity = F9:	/=	45315>43G	7<891>	45	B./012345?	B4C18>	45	3E1	>3.9239.1@9:A1.	/=	B4C18>	4D1534=41D	<>	B./012345?	45	3E1	>3.9239.1  478 
• Projection energy = -./01234/5	D15>43GB./01234/5	45315>43G 479 
 480 
We chose to use projection energy as it directly relates signal strength (pixel intensity) to the 481 
size of a give structure (total number of pixels in the structure), in this case a widely spread 482 
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weak signal and a narrow strong signal may both have similar projection energies. Projection 483 
energy was normalized across different experiments dividing by the injection volume. 484 
Projection signal in injection area was excluded. More information about the record properties 485 
can be found on the Allen SDK (software development kit) website 486 
https://alleninstitute.github.io/AllenSDK/unionizes.html. Each annotation was assigned a new 487 
additional structure ID to enable the calculation of average projection energy per area. 488 
Entorhinal cortex (EC) output was calculated combining the results of experiments 114472145 489 
(injection site: lateral EC) and 113226232 (injection site: medial EC).  490 
Connectivity analysis was performed using custom Matlab (2018a) code, the code is available 491 
on Github (https://github.com/RobertoDF/BRIO). 492 
Generation of Cre-conditional hM4Di mice 493 
We produced a transgenic mouse line carrying a Cre-conditional hM4Di expression cassette 494 
in the Rosa26 locus. The transgene construct was inserted by recombination-mediated 495 
cassette exchange (RMCE). RMCE relies on recombination events between attB and attP 496 
recognition sites of the RMCE plasmid and genetically modified acceptor embryonic stem 497 
(ES) cells, mediated by the integrase of phage phiC31(Hitz et al., 2007). The RMCE construct 498 
is thereby shuttled into the Rosa26 locus of the ES cells, along with a Neomycin resistance 499 
cassette (fig. S12A). The acceptor cell line IDG3.2-R26.10-3 (I3) was kindly provided by Ralf 500 
Kühn (GSF National Research Centre for Environment and Health, Institute of Developmental 501 
Genetics, Neuherberg, Germany). 502 
We subcloned a Cre-conditional FLEX  (flip-excision) cassette (Schnutgen et al., 2003) into 503 
pRMCE, and inserted a strong CAG promoter (CMV immediate early enhancer/modified 504 
chicken β-actin promoter, from Addgene Plasmid #1378) in front of the FLEX-cassette to 505 
create pRMCE-CAG-Flex. The coding sequence of hM4Di-mKateT was inserted into the FLEX 506 
cassette in reverse orientation to the promoter (fig. S12A). Finally, a rabbit globulin polyA 507 
cassette including stop codons in every reading frame was placed downstream of the FLEX 508 
cassette, in the same direction as hM4Di, in order to prevent unintended transcriptional read-509 
through from potential endogenous promoters. The construct was completely sequenced 510 
before ES cell electroporation. 511 
Electroporation of the RMCE construct together with a plasmid encoding C31int was 512 
performed by the transgene facility of the ‘Research Institute for Experimental Medicine’ (FEM, 513 
Charité, Berlin) according to published protocols (Hitz et al., 2009, Hitz et al., 2007).Recombinant 514 
clones were selected by incubation with 140 µg/ml G418 for at least 7 days. To activate hM4Di 515 
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expression by recombination of the FLEX switch, selected clones were further transfected 516 
transiently with pCAG-Cre-EGFP using Roti-Fect (Carl Roth, Karlsruhe, Germany). G418-517 
resistant clones were analyzed by PCR for successful integration and recombination of the 518 
construct (fig. S12B), using the following primer:  519 
GT001 PGK3’-fw: CACGCTTCAAAAGCGCACGTCTG;  520 
GT002 Neo5’-rev: GTTGTGCCCAGTCATAGCCGAATAG;  521 
GT005 PolyA-fw: TTCCTCCTCTCCTGACTACTCC;  522 
GT006 Rosa3’-rev: TAAGCCTGCCCAGAAGACTC;  523 
GT013 hM4Di3’rec-rev: CAGATACTGCGACCTCCCTA 524 
After verification of correct integration and functional FLEX-switch recombination, we 525 
generated chimeras by blastocyst injection of I3 ES cells. Heterozygous offsprings were 526 
mated with a Flpe deleter mouse line in order to remove the neomycin resistance cassette by 527 
Flp-mediated recombination. 528 
Mice homozygous for the Rosa-CAG-FLEX-hM4Di-mKateT allele are viable and fertile and 529 
show now obvious phenotype. Importantly, application of CNO to these mice does not induce 530 
any behavioral effects. Homozygous Cre-conditional hM4Di transgenic mice and Som-Cre 531 
mice (Taniguchi et al., 2011) were maintained on a C57BL/6n genetic background and were 532 
bred to obtain heterozygous Som-Cre / hM4Di offsprings.  533 
Histological analysis 534 
For the post-mortem electrode tracks reconstructions of the in vivo recordings, mice were not 535 
perfused, brain were extracted from the skull, post-fixed in 4% PFA overnight at 4°C and 536 
afterwards cut with a vibratome (Leica Microsystems, Wetzlar Germany) in 100 μM thick 537 
sequential sagittal slices. Images were taken using a 1.25x objective and stitched together 538 
using the microscope software (BX61, Olympus), afterwards we used AllenCCF code 539 
(https://github.com/cortex-lab/allenCCF) to identify electrode shanks location (Shamash et al., 540 
2018). 541 
For the anatomical reconstructions of recorded cells in vitro brain slices were fixed with 4% 542 
paraformaldehyde in 0.1 M phosphate buffer (PB) for at least 24 hours at 4°C. After being 543 
washed three times in 0.1 M PBS, slices were then incubated in PBS containing 1% Triton X-544 
100 and 5% normal goat serum for 4 hr at room temperature (RT). To visualize biocytin-filled 545 
cells we used Streptavidin Alexa 488 conjugate (1:500, Invitrogen), WFS1 (1:1000, Rabbit, 546 
Proteintech, IL, USA) was used in a subset of analysis to visualize the L2/L3 border, Som 547 
(1:1000, Rat, Bachem, Switzerland) was used in the 5-HT2AR localization analysis. Slices were 548 
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incubated with primary antibodies for 48 hours at RT. After rinsing two times in PBS, sections 549 
were incubated in the PBS solution containing 0.5% Triton X-100, Alexa fluor 488, Alexa fluor 550 
555 and Alexa fluor 647 (Invitrogen Corporation, Carlsbad, CA) according to the number of 551 
antibodies used. Slices were mounted in Fluoroshield (Sigma-Aldrich) under coverslips 2-3 hr 552 
after incubation with the secondary antibodies and stored at 4 °C. 553 
Labeled cells were visualized using 20x or 40x objectives on a confocal microscope system 554 
(SP8, Leica). For the 5-HT2AR localization analysis images of the whole EC were acquired and 555 
stitched together using the auto stitching method, with smoothing set to off. Z stacks were 556 
acquired every 30 µM. The Image stacks obtained were registered and combined in Fiji 557 
(http://fiji.sc/wiki/index.php/Fiji) to form a montage of the sections. Cell counting was 558 
executed using Fiji multi-point tool. X-Y-Z coordinates of each 5-HT2AR-EGFP positive cell 559 
were exported to Matlab and subsequently, using custom written code in Matlab, we semi-560 
automatically inspected each cell for colocalization between EGFP(5-HT2AR) and Som. 561 
Statistical Analysis 562 
All datasets were tested to determine normality of the distribution either using D’Agostino-563 
Pearson omnibus normality test or Shapiro-Wilk normality test. Student’s t-test and one-way 564 
ANOVA were used for testing mean differences in normally distributed data. Wilcoxon 565 
matched-pairs signed rank test and Kruskal-Wallis were used for non-normally distributed 566 
datasets. Dunn-Sidak multiple comparison test was used to compare datasets with 3 or more 567 
groups. Kolmogorov-Smirnov test was used to compare cumulative distributions. Statistical 568 
analysis was performed using Prism (6.01) and Matlab (2019a). 569 
All data are expressed as mean ± SEM Asterisks in figures represents p-values smaller than 570 
0.05 unless stated otherwise in the legend. 571 
Data and code availability 572 
The code generated during this study is available from the corresponding author upon 573 
reasonable request. 574 
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Supplementary Figures 582 
Figure 1–figure supplement 1. Regional output connectivity of EC. 583 
(A) Projection energy of all identified EC outputs color coded according to Allen institute 584 
standard: green = cerebral cortex, blue= cerebral nuclei, pink = midbrain, red = 585 
interbrain/hindbrain and yellow = cerebellum. (B) Same data as (A) consolidated in higher level 586 
regions. 587 
  588 
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Figure 1–figure supplement 2. In vivo up-state metrics. 589 
(A) Average up-state voltage deflection, grey patch represents 1 standard deviation (n detected 590 
up-states = 2655, n animals = 18). For each recording the channel with the biggest voltage deflection 591 
was selected, see “Methods”. For experiments with drug application (either MDMA or Fen) 592 
only baseline up-states were taken in account. (B) Violin plots of duration (mean: 0.87 ± 0.008 593 
s), peak 1 amplitude (mean: 218.59 ± 1.83 µV), peak 2 amplitude (mean: 108.27 ± 0.97 µV) 594 
and area (mean: 160.88 ± 1.31 µV·s) of each detected up-state. (C) Scatter plots showing 595 
relationships between metrics used in (B). Bold black number in each plot represent the 596 
correlation coefficient (p < 0.001). 597 
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Figure 1–figure supplement 3. In vivo up-state spatial features. 599 
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(A) Microelectrode implant location and microelectrode features. 64 channels (n animals= 15, n 600 
shanks = 4) and 32 channels (n animals = 3, n shanks = 2) microelectrodes were used in this study, 601 
analysis shown in this figure excludes data recorded with 32 channels probe due to the 602 
different spatial configuration of the channels. (B) Average up-state voltage deflection for each 603 
channel of the microelectrode. For experiments with drug application (either MDMA or Fen) 604 
only baseline up-states were taken in account.  (C) Left: Average up-state voltage deflection 605 
grouped by shank. Right: Average up-state voltage deflection grouped by depths (right). 606 
Insets show the normalized correlation between averages in the two different groups. (D) 607 
Scatter plots showing significant correlation between shank number and peak 1 (left) and 608 
between shank number and peak 1 (right). Bold black number in each plot represent the 609 
correlation coefficient (p < 0.001). (E) Scatter plots showing significant correlation between 610 
recording channel depth and peak 1 (left) and between recording channel depth and peak 1 611 
(right). Bold black number in each plot represent the correlation coefficient (p < 0.001). 612 
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Figure 2–figure supplement 1. Cross-correlogram (CCG) based connectivity analysis. 613 
(A) Units are plotted according to TP latencies and repolarization time and color-coded 614 
according to the number of inhibitory connections detected. Units displaying a TP latency < 615 
0.55 ms were classified as putative inhibitory interneurons (‘Putative int’), the remaining units 616 
were classified as putative excitatory neurons (‘Putative exc’). Inhibitory connections were 617 
detected using Total Spiking Probability Edges (TSPE) (See Supplementary materials). 618 
Putative interneurons had a 40.0 % chance of displaying at least one inhibitory connection in 619 
the CCGs with an average number of 3.38 ± 0.68 inhibitory connections while putative 620 
excitatory cells had a 0.33 % chance of displaying inhibitory connections. (B) Connectivity 621 
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scheme of one putative inhibitory unit (source unit, black circle) displaying 10 inhibitory 622 
connections with surrounding clusters. Grey rhombi represent recording channels on the 623 
probe with the tip of the shanks pointing north. Each colored circle represents the location of 624 
an inhibited unit. Waveforms of the inhibited units are plotted nearby the location using the 625 
same color. Inset shows the location of the source unit on the probe. (C) CCGs of the 626 
connections displayed in (B) using the same color code. Solid lines represent mean, dashed 627 
lines represent 1 standard deviation. 628 
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Figure 2–figure supplement 2. TP latency density distributions. 630 
(A) Dashed lines represent kernel density estimations of probability density functions of the 631 
TP latencies of putative inhibitory (blue), putative excitatory (black) and ‘activated’ units. Solid 632 
lines represent gaussian fitting curves for each group. Peak inhibitory gaussian: 0.31 ms, peak 633 
excitatory gaussian: 0.81 ms and peak ‘activated’ gaussian: 0.56 ms. (B) Goodness of fit 634 
metrics for each gaussian fit. Sse = Sum of squares due to error, rsquare = R-squared 635 
(coefficient of determination), dfe = Degrees of freedom in the error, adjrsquare = Degree-of-636 
freedom adjusted coefficient of determination. 637 
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Figure 3–figure supplement 1. Effect of fenfluramine on SO. 639 
(A) Histogram of UDS incidence before and after fenfluramine application (n= 6, baseline: 1.04 640 
± 0.15 Up-states/10s, fenfluramine: 0.01 ± 0.01 Up-states/10s). (B) Up-state raster plot during 641 
fenfluramine application. (C) Change in resting potential (RP) after fenfluramine application 642 
(n=13, ΔRP = -0.70 ± 1.17 mV).  643 
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Figure 3–figure supplement 2. 5-HT suppresses evoked up-states. 644 
(A) Experimental protocol: recording and stimulation electrode were placed in mEC layer 3, 645 
stimulation electrode was located towards the lateral side of the slice. (B) Effect of electrical 646 
stimulation before (black) and after 5-HT application (orange). 5-HT consistently suppresses 647 
spiking, increasing the stimulation power up to 10 times (n = 40/80 in 4 neurons) had no rescue 648 
effect. Top: voltage responses to electrical stimulation of a representative neuron. Middle: 649 
summary spike raster plot before and after 5-HT application. Bottom: spike rate line histogram 650 
(C) Scatter plot showing area (top, n = 8 neurons,  mean control = 16.22 ± 0.80, , mean5-HT = 1.24 651 
± 0.97, p < 10-4, Wilcoxon matched-pairs signed rank test) and duration (bottom, n = 8 652 
neurons,  mean control = 1.92 ± 0.07, , mean5-HT = 0.24 ± 0.01, , p < 10-4, Wilcoxon matched-653 
pairs signed rank test) of evoked up-states before (black) and after 5-HT application (orange). 654 
(D) Representative voltage responses to 1 second 4 Hz stimulation following wash-in (left) and 655 
wash-out (right) of 5-HT. 5-HT prevents spiking from input summation. 656 
.CC-BY-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted May 26, 2020. . https://doi.org/10.1101/2020.05.26.113373doi: bioRxiv preprint 
  
 
32 
Figure 3–figure supplement 3. 5-HT2ARs are involved in 5-HT mediated SO suppression. 657 
(A) Top: Up-state raster plot during application of WAY 100635 (5-HT1A antagonist) + 5-HT. 658 
Bottom: Change in RP in putative excitatory cells after application of WAY 100635 (5-HT1A 659 
antagonist) + 5-HT (n = 25 cells). (B) Top: Up-state raster plot during application of ketanserin 660 
(5-HT2A antagonist) + 5-HT. Bottom: Change in RP in putative excitatory cells after application 661 
of ketanserin (5-HT2A antagonist) + 5-HT (n = 21 cells). (C) Top: Up-state raster plot during 662 
application of α-methyl-5-HT (5-HT2 agonist). Bottom: Change in RP in putative excitatory 663 
cells after application of α-methyl-5-HT (5-HT2 agonist) (n = 11 cells). (D) Dot plot showing 664 
spiking rate before and after ketanserin + 5-HT (n=20, ketanserin: 0.38 ± 0.14 spikes/s, 665 
ketanserin + 5-HT: 0.15 ± 0.06 spikes/s, p= 0.011, Wilcoxon signed rank test). (E) Dot plot 666 
showing change in RP for each pharmacological condition (5-HT: -4.52 ± 0.64 mV, WAY + 5-667 
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HT: -2.09 ± 0.47 mV, ketanserin + 5-HT: -3.68 ± 0.60 mV and α-methyl-5-HT: -1.67 ± 1.13 668 
mV; p = 0.0329, Kruskal-Wallis with Dunn's multiple comparisons test). (F) Dot plot showing 669 
percentage reduction of up-states incidence for each pharmacological condition (5-HT: 95 ± 670 
4 %, WAY + 5-HT: 100 ± 0 %, ketanserin + 5-HT: 57 ± 10.1 % and α-methyl-5-HT: 100 ± 0 671 
%; p < 10-4, Kruskal-Wallis with Dunn's multiple comparisons test). 672 
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Figure 3–figure supplement 4. LTS neurons are depolarized by 5-HT. 674 
(A) PCA projection plot of all the cells recorded. Cells are color coded according to group 675 
identity: excitatory (black), fast spiking (blue), low-threshold spiking (orange) and layer II 676 
stellate (grey). Empty circles represent PCA loadings. (B) PCA projection plot color coded 677 
according to ΔRP after 5-HT application. Inset shows a recording from one LTS neuron during 678 
5-HT application. Scale bars: 20 mV, 25 s. Dotted line showing -70 mV. (C) PCA projection 679 
plot color coded according to Δspikes/s after 5-HT application. (D) Posterior probability of 680 
being classified as Exc, FS or LTS. 681 
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Figure 3–figure supplement 5. Excitatory, fast-spiking and LTS cells have unique sets of 683 
electrophysiological features. 684 
(A) Box plot showing the values of input resistance (Rin), delta after-hyperpolarization (ΔAHP), 685 
SAG, RP, rheobase and spike width of excitatory (Exc, black), fast spiking (FS, blue) and low-686 
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threshold spiking (LTS, green) cells (nEXC = 33, nFS = 6, nLTS = 9 ; asterisk means p < 0.05, double 687 
asterisk means p < 0.01). (B) Table showing values plotted in (A). 688 
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Figure 3–figure supplement 6. Spatial localization of 5-HT2AR positive cells in EC. 690 
(A) 3D visualization of EC (purple). (B) 3D localization of all the 5-HT2AR positive cells detected 691 
in EC using same perspective as (A). (C and D) Co-localization of 5-HT2AR and Som, arrows 692 
point to colocalized cells (scale bar: 100 µm, n animals= 7, total number of 5-HT2AR positive cells 693 
= 3570, average number of 5-HT2AR positive cells per animal = 510 ± 80.32). (E) Spatial 694 
distribution of 5-HT2AR positive cells and colocalized cells along the 3 dimensions depicted in 695 
(A) (Z dimension centered on the midline). 696 
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Figure 4–figure supplement 1. Vector construction and RMCE for the generation of a 698 
transgenic mouse line with Cre-conditional hM4Di expression. 699 
(A) The coding sequence of hM4Di-mKate flanked by two opposing loxP and lox2272 sites 700 
was placed in reverse orientation to the CAG- promoter in the pRMCE. In the acceptor ES 701 
cells the ROSA26 allele harbours a PGK promoter driving the hygromycin selection marker, 702 
flanked by two attP sites. RMCE by C31int replaces the hygromycin resistance by the 703 
neomycin resistance of the donor vector. Location of primer binding sites in the Rosa26-704 
hM4Di locus is indicated by green triangles. (B) Identification of successful genomic 705 
integration events and Cre-mediated inversion of the hM4Di coding sequence by PCRs. PCR 706 
1 and PCR 2 test for correct integration of the 5’ and 3’ end of the construct into the ROSA26 707 
locus. The lower band in PCR 1 results from the Neomycin resistance cassette of the feeder 708 
cells in the ES cell culture. PCR 3 tests for successful recombination of the FLEX site by Cre. 709 
A successful Cre-mediated recombination of the FLEX cassette was observed for clone 1, 710 
resulting in an 826 bp product in PCR 3. C: control cells (not electroporated), H: H2O input. 711 
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Figure 5–figure supplement 1. CNO application in wildtype littermates and PV-hM4Di 713 
mice. 714 
(A) CNO application in wildtype littermates. Top: Experimental protocol. Orange box 715 
represents 5-HT and purple boxes represent CNO application. Bottom: Up-state incidence 716 
during 5-HT and 5-HT+CNO application, patches represent 95% confidence interval, lines 717 
represent standard deviation (n = 11 cells in 4 mice, mean baseline = 0.91 ± 0.10, mean 5-HT = 0.09 718 
± 0.04, mean CNO = 0.01 ± 0.01, p baseline vs 5-HT = 0.0004, p baseline vs CNO < 10-4, Kruskal-Wallis test) 719 
(B) Same as (A) but in in PV-hM4Di mice (n = 10 cells in 4 mice, mean baseline = 1.02 ± 0.08, 720 
mean5-HT = 0.04 ± 0.03, mean CNO = 0.08 ± 0.07, p baseline vs 5-HT < 10-4, p baseline vs CNO = 0.0003, 721 
Kruskal-Wallis test). 722 
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